{
    "2021-09-07": [
        [
            {
                "time": "2021-08-01",
                "original_text": "沃森生物(300142)2021年中报点评：13价销售放量符合预期 静待mRNA新冠疫苗三期临床结果",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "13价疫苗",
                        "mRNA新冠疫苗",
                        "三期临床"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-06",
                "original_text": "北向资金追平年内最长净买入记录 累计加仓超550亿，美的集团净买入超11亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "美的集团"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "家电"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "沃森生物：公司新冠mRNA疫苗目前在海外获得墨西哥、印尼的三期临床试验批件",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "mRNA新冠疫苗",
                        "三期临床",
                        "墨西哥",
                        "印尼"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-02",
                "original_text": "沃森生物：新冠mRNA疫苗正在开展三期临床试验 生产厂房已竣工交付",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "mRNA新冠疫苗",
                        "三期临床",
                        "生产厂房"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-06",
                "original_text": "A股融资融券日报：两融余额增加117.03亿元（9月6日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-01",
                "original_text": "沃森生物：公司二价HPV疫苗预计2022年可实现生产上市",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "二价HPV疫苗",
                        "生产上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}